Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
「Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。